Biprogy Inc. logo

Biprogy Inc. (NIU)

Market Closed
8 Dec, 20:00
XMUN XMUN
30. 60
0
0%
2.76B Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
30.6
Previous Close
Day Range
30.6 30.6
Year Range
25.8 37.6
Want to track NIU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 56 days

Summary

NIU closed today higher at €30.6, an increase of 0% from yesterday's close, completing a monthly decrease of -6.71% or €2.2. Over the past 12 months, NIU stock gained 5.52%.
NIU is not paying dividends to its shareholders.
The last earnings report, released on Nov 05, 2025, missed the consensus estimates by -85.64%. On average, the company has fell short of earnings expectations by -28.55%, based on the last three reports. The next scheduled earnings report is due on Feb 02, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XMUN (EUR).

NIU Chart

Similar

4B1
China Bohai Bank Co., Ltd.
0.11
0%
9JG
Brookfield Wealth Solutions Ltd.
-
-
Bank of East Asia Ltd. Sponsored ADR
1.44
0%
5AC
HgCapital Trust plc
5.55
0%

Biprogy Inc. (NIU) FAQ

What is the stock price today?

The current price is €30.60.

On which exchange is it traded?

Biprogy Inc. is listed on XMUN.

What is its stock symbol?

The ticker symbol is NIU.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 2.76B.

When is the next earnings date?

The next earnings report will release on Feb 02, 2026.

Has Biprogy Inc. ever had a stock split?

No, there has never been a stock split.

Biprogy Inc. Profile

Insurance Industry
Financials Sector
Mr. Wade Menpes-Smith CEO
XMUN Exchange
- ISIN
Germany Country
3 Employees
28 Mar 2025 Last Dividend
- Last Split
- IPO Date

Overview

Aladdin Healthcare Technologies SE is a pioneering company focusing on the innovative use of blockchain technology to enhance healthcare. By leveraging blockchain, the company ensures secure and efficient storage and management of health-related information. With its subsidiary, Aladdin Healthcare Technologies Ltd, it is at the forefront of harnessing Artificial Intelligence (AI) for the discovery of new drugs and the improvement of healthcare outcomes. The company, founded in 2014 and based in Berlin, Germany, is making significant strides in addressing the challenges posed by age-related diseases, such as Alzheimer's and Parkinson's, as well as emerging threats like SARS-CoV-2.

Products and Services

  • Artificial Intelligence Assisted Drug Discovery Platform

    This platform utilizes AI to speed up the process of discovering small molecule drug compounds that can potentially treat multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. By applying advanced algorithms and machine learning techniques, this platform aims to streamline the drug discovery process, making it faster and more cost-effective.

  • PharmaKG

    PharmaKG is a biomedical knowledge graph that integrates various sources of data to facilitate a deeper understanding of the connections between genes, diseases, drugs, and biological pathways. This comprehensive database aids researchers in uncovering new insights and improving the accuracy of biomedical research outcomes.

  • Disease Diagnosis and Risk Assessment Platform

    This platform leverages AI to provide enhanced diagnostic tools and risk assessment models for healthcare providers. By analyzing vast amounts of health data, it offers more accurate diagnoses and forecasts, contributing to more personalized and effective treatment plans for patients.

Contact Information

Address: Unter den Linden 10
Phone: 49 30 700 140 449